Home » Topics » BioWorld Science

BioWorld Science
RSS

FGF21 switches sides in pancreatitis

Jan. 13, 2020

Curadev Pharma synthesizes new STING agonists

Jan. 13, 2020

New tankyrase 1/2 inhibitors patented by Forschungsverbund Berlin and collaborators

Jan. 13, 2020

Heptares Therapeutics describes new muscarinic acetylcholine M1 and/or M4 receptor agonists

Jan. 13, 2020

Mutations in TTC29 gene linked to male infertility

Jan. 13, 2020

Daiichi Sankyo presents a new orally potent analgesic, DS-54360155

Jan. 13, 2020

Novel ATX inhibitor shows promise as IOP-lowering therapy in vivo

Jan. 13, 2020

Positive results from pivotal phase II study of loncastuximab tesirine in DLBCL

Jan. 13, 2020

Nomacopan achieves primary endpoint at interim analysis of phase III CAPSTONE study

Jan. 13, 2020

Moderna begins phase II study of CMV vaccine mRNA-1647

Jan. 13, 2020

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...